Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma
Aimwell Partners (OTC Pink:AIMN) Aimwell Bio today officially opened applications for its exclusive Founding Cohort, a high-fidelity intelligence network designed to bridge the "Verification Gap" currently exposing medical practitioners and biopharma scientists to unprecedented professional risk.For the first time, individual practitioners are being invited to deploy the same source-verified, hallucination-contained intelligence infrastructure...
Read more








